The CARE‐II (Carotid Atherosclerosis Risk Assessment) Study is a cross‐sectional, observational, multicenter study (NCT02017756) conceived to assess carotid atherosclerotic plaque in Chinese patients ...

Therefore, effective CVD interventions call for precise identification of the plaques to aid in clinical treatment of such diseases. Herein, a reactive oxygen species (ROS)-responsive sequentially ...

EDTA is an intravenous chelating agent with high affinity to divalent cations (lead, cadmium, and calcium) that may be beneficial in the treatment of cardiovascular disease (CVD). Although a large ...